摘要
一氧化氮,从L-精氨酸合成的一氧化氮合酶,在人体是一个复杂的角色。它几乎有助于每一个生理系统,并已被发现在疾病状态下是保护和有毒的。老年人群面临着越来越多的神经退行性疾病的发病率,在未来一氧化氮在阿尔茨海默氏症和帕金森氏症的病理作用可能是重要的治疗目。一氧化氮的保护作用也是很重要的考虑,通过抑制半胱氨酸天冬氨酸蛋白酶-3、亚硝基化天门冬氨酸、蛋白激酶B和环磷腺苷效应元件结合蛋白转录因子的活化增加。一氧化氮已被证明在长时程增强发挥的一部分作用,揭示了其在突触可塑性的重要性。由于一氧化氮的混合效果,这是一个令人兴奋的和不同的治疗靶点。目前,这些疗法的影响已经在动物研究中探索和发展,但尚未完全实现在人体试验。本文概述了在中枢神经系统中病理学和一氧化氮的保护作用,以及潜在的药物治疗和指示目标。
关键词: 一氧化氮,神经退行性疾病,神经保护,阿尔茨海默氏症,帕金森氏症。
Current Medicinal Chemistry
Title:Is Nitric Oxide Assuming a Janus-Face in The Central Nervous System?
Volume: 23 Issue: 16
Author(s): Felicity Ockelford, Louis Saada, Ehud Gazit, Achala de Mel
Affiliation:
关键词: 一氧化氮,神经退行性疾病,神经保护,阿尔茨海默氏症,帕金森氏症。
摘要: Nitric Oxide, synthesized from L-arginine by the nitric oxide synthases, has a complex role within the human body. It contributes to almost every physiological system and has been found to be both protective and toxic in disease states. An aging population faces an increasing incidence of neurodegenerative disease and the pathological action of nitric oxide in Alzheimer’s and Parkinson’s diseases may be important therapeutic targets for the future. Nitric oxide’s protective effects are also important to consider, through inhibition of caspase-3, nitrosylation of NMDA and increased activation of protein kinase B and CREB transcription factor. Nitric oxide has been shown to play a part in long term potentiation, revealing its importance in synaptic plasticity. Due to nitric oxide’s mixed effects it is an exciting and varied therapeutic target. Currently, the impact of these therapies has been explored and developed in animal studies, but is yet to be fully realized in human trials. This paper outlines both the pathological and protective roles of nitric oxide in the central nervous system and the potential pharmacological therapies and targets these indicate.
Export Options
About this article
Cite this article as:
Felicity Ockelford, Louis Saada, Ehud Gazit, Achala de Mel , Is Nitric Oxide Assuming a Janus-Face in The Central Nervous System?, Current Medicinal Chemistry 2016; 23 (16) . https://dx.doi.org/10.2174/0929867323666160316124137
DOI https://dx.doi.org/10.2174/0929867323666160316124137 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Management of Phosphodiesterase-5 (PDE5) Inhibitor Failure
Current Vascular Pharmacology Flaxseed and Endotoxic Shock
Current Pharmaceutical Design Vasospastic Angina and Ca Channel Blockers
Current Hypertension Reviews Risk of Bleeding Related to Antithrombotic Treatment in Cardiovascular Disease
Current Pharmaceutical Design Endothelin Receptor Antagonists: Another Potential Alternative for Cardiovascular Diseases
Current Drug Targets - Cardiovascular & Hematological Disorders The Neuroprotective Effect of Ginkgo biloba Leaf Extract and its Possible Mechanism
Central Nervous System Agents in Medicinal Chemistry Conventional Chemotherapy and Emerging Targeted Therapy for Advanced Adrenocortical Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Hypersensitivity to Antineoplastic Agents
Current Pharmaceutical Design Psychiatric Disorders Associated with FXTAS
Current Psychiatry Reviews Cardiovascular effect of Nigella sativa L. Aqueous Extract in Normal Rats
Cardiovascular & Hematological Disorders-Drug Targets Coumarins as Promising Scaffold for the Treatment of Age-related Diseases – An Overview of the Last Five Years
Current Topics in Medicinal Chemistry Overcoming Drug Resistance by Enhancing Apoptosis of Tumor Cells
Current Cancer Drug Targets Resistant Hypertension in the Elderly-Second Line Treatments: Aldosterone Antagonists, Central Alpha-Agonist Agents, Alpha-Adrenergic Receptor Blockers, Direct Vasodilators, and Exogenous Nitric Oxide Donors
Cardiovascular & Hematological Agents in Medicinal Chemistry Biological Properties of Baicalein in Cardiovascular System
Current Drug Targets - Cardiovascular & Hematological Disorders The Hypothalamic-Neurohypophyseal System: Current and Future Treatment of Vasopressin and Oxytocyn Related Disorders
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) PDE-5 Inhibitors: Clinical Points
Current Drug Targets Increased Risk of Falls, Fall-related Injuries and Fractures in People with Type 1 and Type 2 Diabetes - A Nationwide Cohort Study
Current Drug Safety Pharmacology of Nitric Oxide: Molecular Mechanisms and Therapeutic Strategies
Current Pharmaceutical Design Ischemic and Oxidative Damage to the Hypothalamus May Be Responsible for Heat Stroke
Current Neuropharmacology Spermine Metabolism and Anticancer Therapy
Current Cancer Drug Targets